ArticleAntimicrobial agents and chemotherapy2014

Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation.

Matthew L Rizk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.